c-Myc Antibody Blocking Peptide
Novus Biologicals | Catalog # NB600-336PEP
Loading...
Loading...
Product Specifications
Description
A MYC antibody blocking peptide.
Predicted Molecular Mass
48.8 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Application Notes
This peptide is useful as a blocking peptide for NB600-336. For further blocking peptide related protocol, click here.
Protein / Peptide Type
Antibody Blocking Peptide
Formulation, Preparation, and Storage
NB600-336PEP
| Formulation | dH2O |
| Concentration | 1.0 mg/ml |
| Shipping | The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage | Store at -80C. Avoid freeze-thaw cycles. |
Background: c-Myc
A basic Helix-Loop-Helix, Leucine Zipper domain (bHLH/LZ), designated Max, specifically associates with c-Myc, N-Myc and L-Myc proteins. The Myc-Max complex binds to DNA in a sequence-specific manner under conditions where neither Max nor Myc exhibit appreciable binding. Max can also form heterodimers with other bHLH-Zip proteins, Mad and Mxi1. c-Myc plays a role in cell cycle progression, apoptosis, cellular transformation and angiogenesis (2). Mutations, overexpression, rearrangement and translocation of this gene have been associated with a variety of cancers including B-cell Lymphomas, acute myeloid leukemia, glioblastoma, stomach adenocarcinoma, and prostate adenocarcinoma (3).
References
1. Wilkinson, D. S., Tsai, W. W., Schumacher, M. A., & Barton, M. C. (2008). Chromatin-bound p53 anchors activated Smads and the mSin3A corepressor to confer transforming-growth-factor-beta-mediated transcription repression. Mol Cell Biol, 28(6), 1988-1998. doi:10.1128/mcb.01442-07
2. Pedrosa, A. R., Bodrug, N., Gomez-Escudero, J., Carter, E. P., Reynolds, L. E., Georgiou, P. N.,... Hodivala-Dilke, K. M. (2019). Tumor Angiogenesis Is Differentially Regulated by Phosphorylation of Endothelial Cell Focal Adhesion Kinase Tyrosines-397 and -861. Cancer Res, 79(17), 4371-4386. doi:10.1158/0008-5472.Can-18-3934
3. Nagasaka, M., Tsuzuki, K., Ozeki, Y., Tokugawa, M., Ohoka, N., Inoue, Y., & Hayashi, H. (2019). Lysine-Specific Demethylase 1 (LSD1/KDM1A) Is a Novel Target Gene of c-Myc. Biol Pharm Bull, 42(3), 481-488. doi:10.1248/bpb.b18-00892
Long Name
v-Myc Avian Myelocytomatosis Viral Oncogene Homolog (Avian)
Alternate Names
cMyc, Myc, Myc2, Niard, Nird
Gene Symbol
MYC
Additional c-Myc Products
Product Documents for c-Myc Antibody Blocking Peptide
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Product Specific Notices for c-Myc Antibody Blocking Peptide
This product is for research use only and is not approved for use in humans or in clinical diagnosis. This product is guaranteed for 1 year from date of receipt.
Customer Reviews for c-Myc Antibody Blocking Peptide
There are currently no reviews for this product. Be the first to review c-Myc Antibody Blocking Peptide and earn rewards!
Have you used c-Myc Antibody Blocking Peptide?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
FAQs for c-Myc Antibody Blocking Peptide
Showing
1
-
3 of
3 FAQs
Showing All
-
Q: Has this peptide been used as an absorption control for immunostaining with the c-myc antibody clone 9E10? What is the effective concentration of peptide per ml of optimally diluted antibody? Are there any punblications citing this procedure?
A:
Our c-Myc peptide NB600-336PEP is a blocking peptide specific to our c-Myc antibody NB600-336. The NB600-336PEP peptide is a synthetic peptide made to the human c-Myc protein (between residues 400-450) [UniProt P01106]. We have tested this peptide in a western blot competition assay with our NB600-336 antibody. We used the peptide at a 50-200 molar excess of the antibody. This translates to approximately 5-10ug of peptide to every 1ug of antibody. Currently, we do not have any published reference using this peptide.
-
Q: What is the sequence?
A: Our sequence is considered proprietary, but we utilized a synthetic peptide made to the human c-Myc protein (between residues 400-450). Residues 400-450 contains the region used universally to c-Myc tag proteins.
-
Q: What is the size of this protein in kDa?
A: This peptide was used to generate our c-Myc antibody NB600-336. This is just the c-Myc epitope tag so it's only about 1kDa. This peptide is intended to be a blocking peptide rather than for use in Western blot. 9E10 is also a commercial available antibody against the c-Myc tag, so this should work just fine.
-
Q: Has this peptide been used as an absorption control for immunostaining with the c-myc antibody clone 9E10? What is the effective concentration of peptide per ml of optimally diluted antibody? Are there any punblications citing this procedure?
A:
Our c-Myc peptide NB600-336PEP is a blocking peptide specific to our c-Myc antibody NB600-336. The NB600-336PEP peptide is a synthetic peptide made to the human c-Myc protein (between residues 400-450) [UniProt P01106]. We have tested this peptide in a western blot competition assay with our NB600-336 antibody. We used the peptide at a 50-200 molar excess of the antibody. This translates to approximately 5-10ug of peptide to every 1ug of antibody. Currently, we do not have any published reference using this peptide.
-
Q: What is the sequence?
A: Our sequence is considered proprietary, but we utilized a synthetic peptide made to the human c-Myc protein (between residues 400-450). Residues 400-450 contains the region used universally to c-Myc tag proteins.
-
Q: What is the size of this protein in kDa?
A: This peptide was used to generate our c-Myc antibody NB600-336. This is just the c-Myc epitope tag so it's only about 1kDa. This peptide is intended to be a blocking peptide rather than for use in Western blot. 9E10 is also a commercial available antibody against the c-Myc tag, so this should work just fine.
-
Q: Has this peptide been used as an absorption control for immunostaining with the c-myc antibody clone 9E10? What is the effective concentration of peptide per ml of optimally diluted antibody? Are there any punblications citing this procedure?
A:
Our c-Myc peptide NB600-336PEP is a blocking peptide specific to our c-Myc antibody NB600-336. The NB600-336PEP peptide is a synthetic peptide made to the human c-Myc protein (between residues 400-450) [UniProt P01106]. We have tested this peptide in a western blot competition assay with our NB600-336 antibody. We used the peptide at a 50-200 molar excess of the antibody. This translates to approximately 5-10ug of peptide to every 1ug of antibody. Currently, we do not have any published reference using this peptide.
-
Q: What is the sequence?
A: Our sequence is considered proprietary, but we utilized a synthetic peptide made to the human c-Myc protein (between residues 400-450). Residues 400-450 contains the region used universally to c-Myc tag proteins.
-
Q: What is the size of this protein in kDa?
A: This peptide was used to generate our c-Myc antibody NB600-336. This is just the c-Myc epitope tag so it's only about 1kDa. This peptide is intended to be a blocking peptide rather than for use in Western blot. 9E10 is also a commercial available antibody against the c-Myc tag, so this should work just fine.
